$103.87
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. The company is headquartered in Woonsocket, Rhode Island and currently employs 300,000 full-time employees. The firm's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. The Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and, through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.
Country

US

CEO

Mr. J. David Joyner

IPO date

1952

Employees

259,500

ISIN

US1266501006

Key stats

Open

$102.84

Volume

8.48M

Market cap

$131.18B

Prev. close

$102.81

Impl / hst vl

-

Open interest

$0.00

$102.40

Day’s Range

$103.87

$69.51

52W Range

$106.15

Valuation

33
Valuation score
Overvalued
P/E
45.54
P/S
0.33
P/B
1.72
Current ratio
0.87
Debt / Equity
0.69
ROE
3.87%
Gross margin
15.56%
Income growth
-
FCF growth
30.47

May

4

Dividends

The last payment date was May 4, 2026

Div. per Share

$0.67

Div. Yield

0.65%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Buy

The average rating from top 20 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$105.15
The top 28 analysts forecasts that 12-month price may increase by 1.24%, with a low of $79.79 and a high of $120.75
$79.79
Low
$105.15
Avg
$120.75
High
Current price

Earnings

Q1 ‘26 revenue
$100.43B
Q1 ‘26 net income
$2.94B
Revenue
Net income
Previous EPS
$2.57
Estimate EPS
$1.85
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply